These data indicated that the simultaneous gene silencing with dual-siRNA achieve therapeutic efficacy on pulmonary fibrosis through impeding the interaction between and cooperation of PTPN13 and NOX4 in fibrosis development. This evidence concerns the gene PTPN13 and pulmonary fibrosis.